Osaka, Japan

Fumiyo Yoshida

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumiyo Yoshida. Retrieved from https://idiyas.com/inventor/fumiyo-yoshida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumiyo Yoshida: A Pioneer in Antibiotic Innovation

Introduction: Fumiyo Yoshida, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceuticals. With a focus on improving antibiotic stability, her innovative work has potential wide-reaching implications for medical treatments.

Latest Patents: Yoshida holds a patent for the invention of alpha-crystals of cefazolin sodium. This unique formulation contains a water content ranging from 13.0 to 15.8%, enhancing the antibiotic's thermal and light stability. This innovation represents a significant advancement in the delivery and effectiveness of cefazolin sodium.

Career Highlights: Fumiyo Yoshida is part of Fujisawa Pharmaceutical Company, Ltd., where she has dedicated her career to pharmaceutical research and development. Her work in antibiotic formulation has positioned her as a key player in the quest for more reliable medications.

Collaborations: Throughout her career, Yoshida has collaborated with esteemed colleagues such as Toshinobu Uemura and Keiji Kai. These partnerships have been pivotal in advancing her research and bringing her innovative ideas to fruition.

Conclusion: Fumiyo Yoshida's contributions to antibiotic innovation reflect her dedication to improving healthcare solutions. With her single patent marking a significant milestone in pharmaceutical advancements, she continues to inspire future generations of scientists and inventors in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…